All In MedTech

FDA Clearance Tracker · P220029

Optilume™ BPH Catheter System

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Jun 30, 2023 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

Decided

Jun 30, 2023

Approved

Time to decision

200 days

Received Dec 12, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P220029
Device name
Optilume™ BPH Catheter System
Applicant location
Minneapolis, MN
Received
Dec 12, 2022
Decided
Jun 30, 2023
Decision
Approved
Supplements
4 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code QXB

FDA's approval statement

As written in FDA's record.

Approval for the Optilume BPH Catheter System indicated for the treatment of obstructive urinary symptoms associated with Benign Prostatic Hyperplasia (BPH) in men >= 50 years of age.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code QXB (Drug coated prostatic dilation catheter for benign prostatic hyperplasia).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Urotronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.